Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹110 Cr.
Stock P/E
11.4
P/B
2.4
Current Price
₹191
Book Value
₹ 79.2
Face Value
10
52W High
₹327.5
52W Low
₹ 140
Dividend Yield
0%

Ambar Protein Inds. Overview

Business

Ambar Protein Industries Ltd. is an Indian company primarily engaged in the edible oil sector. Its core business involves the processing of oilseeds to produce edible oils and related by-products. This typically includes crushing oilseeds, refining crude oils, and packaging them for consumer and industrial use. The company generates revenue by selling these edible oils, such as soybean oil, groundnut oil, or palm oil (depending on its specific processing capabilities and raw material sourcing), to various markets, including direct consumers, food manufacturers, and institutional buyers. It may also derive revenue from selling oil cakes or de-oiled cakes, which are by-products used as animal feed.

Revenue Mix

Given its sector, Ambar Protein Industries Ltd.'s primary revenue stream is derived from the manufacturing and sale of edible oils. While specific revenue contribution breakdowns are not provided, it is typical for companies in this industry to have a majority of their revenue coming from refined edible oils, with a smaller but significant portion from the sale of oil meal/cake by-products.

Industry

The Indian edible oil industry is characterized by high consumption driven by a large and growing population, with a significant reliance on imports for crude oil and oilseeds. It is a competitive industry with a mix of large national players and numerous regional/local processors. Ambar Protein Industries Ltd. likely operates within this competitive landscape, potentially focusing on specific regional markets or a particular type of edible oil, positioning itself as a processor and supplier within the value chain. Its positioning against larger, more established national brands would depend on its scale of operations, brand recognition, and distribution network.

MOAT

Without specific details, a company like Ambar Protein Industries Ltd. may seek competitive advantages through:

Cost Efficiency: Optimizing procurement of raw materials (oilseeds) and achieving efficient processing at its facilities to offer competitive pricing.

Distribution Network: Developing a strong regional distribution network to effectively reach retailers and consumers in its target markets.

Operational Scale: If it achieves a certain scale, it can benefit from economies of scale in purchasing and processing.

Product Specialization: Focusing on specific types of edible oils or niches where it can build expertise or market share.

Strong brand loyalty, significant switching costs, or proprietary technology are less common moats in this largely commoditized sector for mid-tier players.

Growth Drivers

Key factors that can drive growth for Ambar Protein Industries Ltd. over the next 3-5 years include:

Rising Consumption: India's growing population and increasing disposable incomes are expected to drive sustained demand for edible oils.

Urbanization and Packaged Goods Trend: A shift from loose oil to branded, packaged edible oils, particularly in urban and semi-urban areas, presents an opportunity for companies with established brands and distribution.

Product Diversification: Expansion into value-added products or different types of edible oils to capture broader market segments.

Infrastructure Improvement: Investments in processing capacity or logistics could enhance market reach and efficiency.

Risks

Raw Material Price Volatility: Fluctuations in the prices of oilseeds (e.g., soybean, groundnut) or crude edible oils, often influenced by global agricultural commodity markets, weather patterns, and import policies, can impact profitability significantly.

Government Policies: Changes in import duties, minimum support prices (MSP) for oilseeds, or other agricultural policies can directly affect costs and market dynamics.

Intense Competition: The Indian edible oil market is highly competitive, leading to pricing pressures and potentially impacting market share and margins.

Supply Chain Disruptions: Issues in sourcing raw materials or distributing finished goods, due to logistical challenges or unforeseen events, can affect operations.

Health and Regulatory Scrutiny: Increasing consumer awareness about health and stricter food safety regulations could necessitate investments in quality control and compliance.

Management & Ownership

Ambar Protein Industries Ltd. is likely a promoter-driven company, common in India, where the founding family or individuals hold significant ownership and are actively involved in management. The quality of management would typically be reflected in their ability to navigate raw material price volatility, manage supply chains effectively, adapt to changing consumer preferences, and maintain operational efficiency in a competitive industry. Ownership structure usually involves the promoter group holding a majority stake, with the remainder held by public shareholders and potentially institutional investors.

Outlook

The outlook for Ambar Protein Industries Ltd. is characterized by the ongoing robust demand for edible oils in India, fueled by demographic trends and economic growth, which provides a foundational growth trajectory. The company's ability to capitalize on this demand will depend on its operational efficiency, effective raw material sourcing, and strength of its distribution network within its target markets. However, it faces inherent industry challenges such as significant raw material price volatility, intense competition, and potential shifts in government import/export policies. Success will hinge on disciplined cost management, strategic market penetration, and potentially, diversification into higher-margin products to mitigate the commodity nature of the business.

Ambar Protein Inds. Share Price

Live · BSE · Inception: 1992
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Ambar Protein Inds. Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 90 93 89 112 128 117 112 125 147 113
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 90 93 89 112 128 117 112 125 147 114
Total Expenditure 90 90 85 107 124 115 109 122 143 108
Operating Profit -0 3 4 5 4 2 3 3 4 6
Interest 0 1 1 1 1 1 0 1 1 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -1 2 4 4 3 1 2 3 3 5
Provision for Tax -1 1 1 1 1 1 -0 1 1 1
Profit After Tax -0 2 3 3 2 1 2 2 2 4
Adjustments 0 -0 0 0 -0 0 0 0 0 -0
Profit After Adjustments -0 2 3 3 2 1 2 2 2 4
Adjusted Earnings Per Share -0.8 3 4.7 4.9 4.3 1.3 3.5 3.2 4.3 6.5

Ambar Protein Inds. Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 157 168 195 206 231 284 313 340 345 337 422 497
Other Income 1 0 1 1 0 0 0 1 1 0 1 0
Total Income 158 169 196 207 231 285 314 340 346 338 422 498
Total Expenditure 155 167 193 203 227 278 306 331 338 330 406 482
Operating Profit 2 2 3 4 4 7 8 10 8 8 17 16
Interest 1 1 1 1 1 3 3 3 3 2 2 2
Depreciation 0 0 0 0 0 1 1 1 1 1 1 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 2 1 2 3 3 3 4 6 4 4 13 13
Provision for Tax 0 1 0 1 1 2 1 1 1 1 3 3
Profit After Tax 2 1 2 2 2 1 3 4 3 3 10 10
Adjustments 0 0 0 0 0 0 0 -0 0 0 0 0
Profit After Adjustments 2 1 2 2 2 1 3 4 3 3 10 10
Adjusted Earnings Per Share 2.7 1.5 4.2 3.7 3.5 2.2 6 7.7 4.9 5.5 16.8 17.5

Ambar Protein Inds. Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 4 6 6 8 10 11 15 19 22 25 35
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 4 5 4 4 3 2 0 0
Other Non-Current Liabilities 0 -1 2 1 3 4 3 3 3 2 2
Total Current Liabilities 9 11 15 18 36 31 29 39 35 34 33
Total Liabilities 13 17 23 31 53 49 50 64 62 61 71
Fixed Assets 4 6 6 6 7 22 21 21 20 19 18
Other Non-Current Assets 0 0 0 6 16 0 0 0 2 1 4
Total Current Assets 8 10 17 19 31 27 29 43 41 41 48
Total Assets 13 17 23 31 53 49 50 64 62 61 71

Ambar Protein Inds. Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 2 1 2 3 1 2 1 1 1 1
Cash Flow from Operating Activities 1 -1 -3 1 1 3 1 -3 6 7 2
Cash Flow from Investing Activities 0 -1 0 -5 -10 -1 -0 -0 0 -0 -0
Cash Flow from Financing Activities -1 1 3 6 7 -0 -2 2 -6 -7 -2
Net Cash Inflow / Outflow 0 -1 1 1 -2 1 -1 -0 0 -0 0
Closing Cash & Cash Equivalent 2 1 2 3 1 2 1 1 1 1 1

Ambar Protein Inds. Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 2.7 1.51 4.19 3.75 3.54 2.17 6 7.74 4.89 5.47 16.78
CEPS(Rs) 3.12 1.91 4.54 4.18 3.99 4.14 8.09 9.97 7.11 7.76 19.06
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 4.24 8.48 10.02 13.77 17.31 19.48 25.48 33.21 38.13 43.6 60.39
Core EBITDA Margin(%) 1.09 1.16 1.29 1.47 1.68 2.12 2.35 2.7 2.09 2.19 3.74
EBIT Margin(%) 1.41 1.16 1.62 1.78 1.75 1.89 2.11 2.53 1.88 1.95 3.63
Pre Tax Margin(%) 0.99 0.81 1.26 1.42 1.23 0.97 1.27 1.74 1.15 1.22 3.09
PAT Margin (%) 0.99 0.52 1.23 1.05 0.88 0.44 1.1 1.31 0.82 0.93 2.29
Cash Profit Margin (%) 1.14 0.65 1.34 1.17 0.99 0.84 1.48 1.69 1.18 1.32 2.6
ROA(%) 11.86 5.91 12.14 7.99 4.85 2.43 6.93 7.78 4.45 5.09 14.63
ROE(%) 99.23 23.82 45.24 31.5 22.76 11.79 26.69 26.38 13.72 13.39 32.28
ROCE(%) 27.73 18.69 22.17 17.45 13.38 14.84 16.53 18.33 12.59 12.91 27.5
Receivable days 2.53 2.32 5.35 5.23 2.29 2.26 3.23 6.74 12.35 15.3 14.83
Inventory Days 10.35 13.12 15.9 15.67 23.69 23.06 18.48 23.68 24.42 21.38 17.51
Payable days 11.62 10.14 9.37 7.22 7.64 5.83 3.83 6.44 7.87 7.95 5.01
PER(x) 0 0 0 0 0 0 0 3.83 43.81 26.6 12.1
Price/Book(x) 0 0 0 0 0 0 0 0.89 5.62 3.34 3.36
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.06 0.07 0.07 0.1 0.13 0.1 0.1 0.14 0.44 0.32 0.34
EV/Core EBITDA(x) 3.98 5.61 4.2 5.2 6.77 4.57 4.02 4.9 19.5 13.69 8.52
Net Sales Growth(%) -2.02 7.41 15.89 5.52 11.9 23.34 10.18 8.44 1.57 -2.28 25.03
EBIT Growth(%) 205.49 -11.32 61.81 15.48 9.92 33.77 23.04 29.8 -24.52 1.32 132.69
PAT Growth(%) 1881.54 -43.94 176.34 -10.49 -5.62 -38.69 176.65 29.02 -36.78 11.82 206.77
EPS Growth(%) 1881.53 -43.94 176.35 -10.49 -5.62 -38.69 176.65 29.03 -36.78 11.82 206.77
Debt/Equity(x) 1.38 1.07 1.8 2.26 2.45 2.41 1.86 1.72 1.34 1.02 0.75
Current Ratio(x) 0.86 0.92 1.1 1.06 0.86 0.88 1 1.11 1.15 1.21 1.45
Quick Ratio(x) 0.37 0.23 0.49 0.59 0.26 0.41 0.4 0.43 0.6 0.61 0.84
Interest Cover(x) 3.37 3.34 4.42 5.04 3.38 2.05 2.51 3.2 2.56 2.68 6.75
Total Debt/Mcap(x) 0 0 0 0 0 0 0 1.92 0.24 0.3 0.22

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +25% +7% +8% +10%
Operating Profit CAGR +113% +19% +19% +24%
PAT CAGR +233% +36% +58% +17%
Share Price CAGR -33% -1% +68% —
ROE Average +32% +20% +22% +32%
ROCE Average +28% +18% +18% +18%

Ambar Protein Inds. Shareholding Pattern

Latest · Sep 2026
100% held
Promoters 73.87 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 26.13 %
# Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Promoter 70.9971.3571.3571.3571.3571.4872.0772.6973.7673.87
FII 0000000000
DII 0000000000
Public 29.0128.6528.6528.6528.6528.5227.9327.3126.2426.13
Others 0000000000
Total 100100100100100100100100100100

Ambar Protein Inds. Peer Comparison

Edible Oil Edit Columns

Ambar Protein Inds. Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Ambar Protein Inds. Pros & Cons

Pros

  • Company has delivered good profit growth of 58% CAGR over last 5 years
  • Debtor days have improved from 7.95 to 5.01days.

Cons

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp